Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrudential Regulatory News (PRU)

Share Price Information for Prudential (PRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 735.20
Bid: 736.40
Ask: 736.80
Change: -7.40 (-1.00%)
Spread: 0.40 (0.054%)
Open: 750.40
High: 758.80
Low: 735.20
Prev. Close: 742.60
PRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Supplementary Prospectus

25 Apr 2017 15:30

RNS Number : 2978D
Prudential PLC
25 April 2017
 

 

 

25 April 2017

Publication of Supplementary Prospectus

The following supplementary prospectus has been approved by the UK Listing Authority and is available for viewing:

Supplementary Prospectus dated 25 April, 2017 (the "Supplementary Prospectus") to the prospectus dated 16 May, 2016 (the "Prospectus"), relating to Prudential PLC's £6,000,000,000 Medium Term Note Programme.

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/2978D_1-2017-4-25.pdf

A copy of the Supplementary Prospectus and the documents incorporated by reference therein will be submitted to the National Storage Mechanism and will shortly be available for inspection at www.Hemscott.com/nsm.do.

This site is not provided for, or directed at, persons in the United States. If you are viewing this page from the United States, you should exit this section of the site.

Prudential plc is not affiliated in any manner with Prudential Financial, Inc. a company whose principal place of business is in the United States of America.

Enquiries to:

Media:

 

Investors/Analysts:

 

Jonathan OliverTom Willetts

+44 (0)20 7548 3719+44 (0)20 7548 2776

Raghu HariharanRichard Gradidge

William Elderkin

+44 (0)20 7548 2871+44 (0)20 7548 3860

+44 (0) 20 3480 5590

DISCLAIMERPlease note that the information contained in the Supplementary Prospectus and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus (as supplemented by the Supplementary Prospectus) is not addressed. Prior to relying on the information contained in the Prospectus (as supplemented by the Supplementary Prospectus) you must ascertain from the Prospectus (as supplemented by the Supplementary Prospectus) whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

Neither the Prospectus nor the Supplementary Prospectus constitutes an offer of securities for sale in the United States. The securities described in this announcement have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended, or under any relevant securities laws of any state of the United States of America and may not be offered, sold or delivered in the United States of America or to, or for the account of or benefit of, U.S. Persons, subject to certain limited exemptions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PSPSEDFLIFWSESL
Date   Source Headline
22nd Apr 20248:34 amRNSNotice of AGM
18th Apr 20249:00 amRNSBLOCK LISTING APPLICATION
12th Apr 202410:01 amRNSDirector/PDMR Shareholding
28th Mar 20241:44 pmRNSDirector/PDMR Shareholding
28th Mar 20249:37 amRNSTotal Voting Rights
27th Mar 20242:34 pmRNSDirector/PDMR Shareholding
27th Mar 20242:28 pmRNSDirector/PDMR Shareholding
27th Mar 202410:08 amRNSOverseas Regulatory Announcement - Grant of Awards
26th Mar 20242:41 pmRNSAnnual Report and Accounts 2023 and Form 20-F
20th Mar 202411:33 amRNSDividend Declaration
20th Mar 202411:33 amRNSPrudential plc – FY23 Results – Additional Info
20th Mar 202411:33 amRNSPrudential plc – FY23 Results – EEV
20th Mar 20248:10 amRNSDividend Declaration
20th Mar 20248:09 amRNSPrudential plc – FY23 Results – Additional Info
20th Mar 20248:08 amRNSPrudential plc – FY23 Results – EEV
20th Mar 20248:03 amRNSPrudential plc – FY23 Results – IFRS
12th Mar 20249:52 amRNSDirector/PDMR Shareholding
29th Feb 202411:08 amRNSTotal Voting Rights
14th Feb 20248:47 amRNSDirector/PDMR Shareholding
31st Jan 20248:53 amRNSTotal Voting Rights
25th Jan 20249:02 amRNSBoard changes
16th Jan 20246:02 pmRNSCompletion of Share Repurchase Programme
16th Jan 20245:56 pmRNSTransaction in Own Shares
15th Jan 20245:45 pmRNSTransaction in Own Shares
12th Jan 20245:49 pmRNSTransaction in Own Shares
11th Jan 20246:04 pmRNSTransaction in Own Shares
11th Jan 20249:53 amRNSDirector/PDMR Shareholding
10th Jan 20246:07 pmRNSTransaction in Own Shares
9th Jan 20245:49 pmRNSTransaction in Own Shares
8th Jan 20245:58 pmRNSTransaction in Own Shares
5th Jan 20248:35 amRNSRepurchase to neutralise share scheme issuance
29th Dec 20238:47 amRNSTotal Voting Rights
20th Dec 20237:00 amRNSPrudential & CITIC provide growth capital for CPL
14th Dec 202310:37 amRNSDirector/PDMR Shareholding
12th Dec 202310:04 amRNSDirector/PDMR Shareholding
30th Nov 202311:54 amRNSTotal Voting Rights
30th Nov 202311:47 amRNSBLOCK LISTING SIX MONTHLY RETURN
16th Nov 20239:17 amRNSBLOCK LISTING APPLICATION
14th Nov 20238:47 amRNSDirector/PDMR Shareholding
6th Nov 20237:19 amRNSPrudential plc - Q3 Business Performance Update
31st Oct 20239:12 amRNSTotal Voting Rights
30th Oct 202311:27 amRNSDirector/PDMR Shareholding
12th Oct 20239:49 amRNSDirector/PDMR Shareholding
9th Oct 20239:44 amRNSDividend Rate Achieved
3rd Oct 202310:31 amRNSOverseas Regulatory Announcement-Grant of Options
3rd Oct 202310:29 amRNSOverseas Regulatory Announcement-Grant of Options
29th Sep 20239:41 amRNSTotal Voting Rights
26th Sep 202310:00 amRNSDirector/PDMR Shareholding
14th Sep 202310:25 amRNS2023 Half-year Report
13th Sep 20239:59 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.